Source:http://linkedlifedata.com/resource/pubmed/id/18227069
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2008-3-31
|
pubmed:abstractText |
The serotonin transporter (SERT) on the plasma membrane is the major mechanism for the clearance of plasma serotonin (5-hydroxytryptamine (5HT)). The uptake rates of cells depend on the density of SERT molecules on the plasma membrane. Interestingly, the number of SERT molecules on the platelet surface is down-regulated when plasma 5HT ([5HT](ex)) is elevated. It is well reported that stimulation of cells with high [5HT](ex) induces transamidation of a small GTPase, Rab4. Modification with 5HT stabilizes Rab4 in its active, GTP-bound form, Rab4-GTP. Although investigating the mechanism by which elevated plasma 5HT level down-regulates the density of SERT molecules on the plasma membrane, we studied Rab4 and SERT in heterologous and platelet expression systems. Our data demonstrate that, in response to elevated [5HT](ex), Rab4-GTP co-localizes with and binds to SERT. The association of SERT with Rab4-GTP depends on: (i) 5HT modification and (ii) the GTP-binding ability of Rab4. Their association retains transporter molecules intracellularly. Furthermore, we mapped the Rab4-SERT association domain to amino acids 616-624 in the cytoplasmic tail of SERT. This finding provides an explanation for the role of the C terminus in the localization and trafficking of SERT via Rab4 in a plasma 5HT-dependent manner. Therefore, we propose that elevated [5HT](ex)"paralyzes" the translocation of SERT from intracellular locations to the plasma membrane by controlling transamidation and Rab4-GTP formation.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
283
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9388-98
|
pubmed:dateRevised |
2011-5-5
|
pubmed:meshHeading |
pubmed-meshheading:18227069-Animals,
pubmed-meshheading:18227069-Blood Platelets,
pubmed-meshheading:18227069-CHO Cells,
pubmed-meshheading:18227069-Cell Membrane,
pubmed-meshheading:18227069-Cricetinae,
pubmed-meshheading:18227069-Cricetulus,
pubmed-meshheading:18227069-Cytoplasm,
pubmed-meshheading:18227069-Down-Regulation,
pubmed-meshheading:18227069-Guanosine Triphosphate,
pubmed-meshheading:18227069-HeLa Cells,
pubmed-meshheading:18227069-Humans,
pubmed-meshheading:18227069-Protein Processing, Post-Translational,
pubmed-meshheading:18227069-Protein Structure, Tertiary,
pubmed-meshheading:18227069-Protein Transport,
pubmed-meshheading:18227069-Serotonin,
pubmed-meshheading:18227069-Serotonin Plasma Membrane Transport Proteins,
pubmed-meshheading:18227069-rab4 GTP-Binding Proteins
|
pubmed:year |
2008
|
pubmed:articleTitle |
Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter.
|
pubmed:affiliation |
Department of Biochemistry and Molecular Biology, College of Medicine, University of Arkansas for Medical Sciences, 301 West Markham Street, Little Rock, AR 72205, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|